Rowe Price Health Sciences Fund (PRHSX) focuses on innovation-driven growth in biotechnology and life sciences. Let’s face it – people will always need healthcare. Whether it’s lifesaving ...

In accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, The Biotech Growth Trust PLC (the "Company") announces the following: As at 31 December 2024, the ...

CEO of Trinity Biotech. "With this additional liquidity and the recent WHO approval, we are well-positioned to accelerate growth and profitability." Founded in the late 1990s by Andrew Mariathasan ...

FibroBiologics, Inc. ( (FBLG) ) has issued an announcement.

Exicure, Inc., an early-stage biotechnology company, has announced the signing of a Memorandum of Understanding (MoU) with GPCR Therapeutics, Inc., a clinical-stage international biopharmaceutical ...

Puma Biotechnology (PBYI) announced that the National Comprehensive Cancer Network, or NCCN, Clinical Practice Guidelines in Oncology for Cervical Cancer were updated to include an addition ...

Exicure (NASDAQ:XCUR) signed a MOU with GPCR Therapeutics aimed at the acquisition of GPCR USA, a subsidiary of GPCR Therapeutics, and the technology transfer and collaborative research on GPCR ...

Let's review some notable picks from our screened stocks. Overview: Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

By acquiring excellent research personnel and clinical pipelines, Exicure aims to advance as a clinical-stage biotech company. GPCR Therapeutics plans to successfully finalize ongoing clinical ...

Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 18 July 2024 to make market purchases of the Company's own shares up to an aggregate ...